ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1852

Decreased Expression of Sirtuin 7 By Lung Fibroblasts from Patients with Scleroderma Contributes to Elevated Collagen Production

Anne E. Wyman1,2, Zahid Noor1, Nevins W. Todd1,2, Irina G. Luzina1,2 and Sergei P. Atamas1,2, 1University of Maryland School of Medicine, Baltimore, MD, 2Baltimore VA Medical Center, Baltimore, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fibroblasts, fibrosis, Lung, mechanisms and scleroderma

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Pulmonary fibrosis is a severe complication of systemic sclerosis (SSc). Changes in the expression levels of sirtuins (SIRTs), a family of NAD+-dependent histone deacetylases, have been reported recently in patients with SSc and other fibrotic diseases, implying a possible pathophysiologic role. Out of 7 known human SIRTs, SIRT1 has received the most attention. We have comparatively assessed the mRNA and protein expression of all SIRTs in primary lung fibroblasts from scleroderma patients with pulmonary fibrosis, idiopathic pulmonary fibrosis (IPF), and from healthy controls, and begun addressing mechanistic implications of the observed differences.

Methods:  mRNA levels of SIRT1-7 were measured by RT-qPCR in lung tissue and fibroblasts from scleroderma patients with lung fibrosis and patients with IPF, as well as from healthy controls; protein levels were measured by western blotting. Intracellular delivery of SIRT7-encoding plasmid constructs and SIRT7-inhibiting siRNA to cultured adult normal human lung fibroblasts was performed by electroporation. The effects of SIRT7 on mRNA of collagen chains COL1A1, COL1A2, and COL3A1 and on protein levels of type I collagen, with and without stimulation with recombinant TGF-β, were assessed.

Results:  mRNA and protein levels of all SIRTs tended to be lower in lung tissues and fibroblasts from patients with fibrosis compared to controls, but the levels of SIRT7 mRNA and protein in pulmonary fibroblasts were significantly lower, particularly in scleroderma (p<0.001 for SIRT7 mRNA and p=0.019 for SIRT7 protein). SIRT7 overexpression in fibroblast cultures inhibited basal and TGF-β-induced levels of collagen, reducing COL1A1 mRNA levels by 5 to 10 fold, COL1A2 mRNA by 2 to 3 fold, and COL3A1 by 3 to 5 fold; the levels of collagen protein were reduced by ~3 fold. SIRT7 silencing increased collagen protein by ~2 fold.

Conclusion:  Pulmonary fibrosis is characterized by lower levels of sirtuins, with a particularly notable decrease in SIRT7 in scleroderma. Overexpression of SIRT7 decreases collagen mRNA and protein levels in cultured lung fibroblasts and attenuates TGF-β-induced increases in collagen. These findings identify SIRT7 as a pathophysiologic contributor to lung fibrosis.


Disclosure: A. E. Wyman, None; Z. Noor, None; N. W. Todd, None; I. G. Luzina, None; S. P. Atamas, None.

To cite this abstract in AMA style:

Wyman AE, Noor Z, Todd NW, Luzina IG, Atamas SP. Decreased Expression of Sirtuin 7 By Lung Fibroblasts from Patients with Scleroderma Contributes to Elevated Collagen Production [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/decreased-expression-of-sirtuin-7-by-lung-fibroblasts-from-patients-with-scleroderma-contributes-to-elevated-collagen-production/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/decreased-expression-of-sirtuin-7-by-lung-fibroblasts-from-patients-with-scleroderma-contributes-to-elevated-collagen-production/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology